G. Giles, How important are estimates of cancer prevalence?, Annals of Oncology, vol.13, issue.6, pp.815-821, 2002.
DOI : 10.1093/annonc/mdf204

A. Micheli, E. Mugno, V. Krogh, M. Quinn, M. Coleman et al., Cancer prevalence in European registry areas, Annals of Oncology, vol.13, issue.6, pp.840-65, 2002.
DOI : 10.1093/annonc/mdf127

M. Colonna, A. Danzon, P. Delafosse, N. Mitton, S. Bara et al., Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012, European Journal of Cancer, vol.44, issue.1, pp.115-137, 2008.
DOI : 10.1016/j.ejca.2007.10.022

URL : https://hal.archives-ouvertes.fr/inserm-00332710

G. Engholm, J. Ferlay, N. Christensen, F. Bray, M. Gjerstorff et al., NORDCAN ??? a Nordic tool for cancer information, planning, quality control and research, Acta Oncologica, vol.59, issue.9, pp.725-761, 2010.
DOI : 10.1093/jnci/djm249

E. Crocetti, D. Angelis, R. Buzzoni, C. Mariotto, A. Storm et al., Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability, British Journal of Cancer, vol.96, issue.1, pp.219-247, 2013.
DOI : 10.1002/hec.1307

F. Bray, J. Ren, E. Masuyer, and J. Ferlay, Global estimates of cancer prevalence for 27 sites in the adult population in 2008, International Journal of Cancer, vol.103, issue.Suppl 8, pp.1133-1178, 2013.
DOI : 10.1002/ijc.27711

P. Pisani, F. Bray, and D. Parkin, Estimates of the world-wide prevalence of cancer for 25 sites in the adult population, International Journal of Cancer, vol.37, issue.1, pp.72-81, 2002.
DOI : 10.1002/ijc.1571

A. Belot, P. Grosclaude, N. Bossard, E. Jougla, E. Benhamou et al., Cancer incidence and mortality in France over the period, 1980.
URL : https://hal.archives-ouvertes.fr/hal-00538673

V. Jooste, P. Grosclaude, L. Remontet, G. Launoy, I. Baldi et al., Unbiased estimates of long-term net survival of solid cancers in France, International Journal of Cancer, vol.49, issue.10
DOI : 10.1002/ijc.27857

S. Bashir and J. Estève, Analysing the difference due to risk and demographic factors for incidence or mortality, International Journal of Epidemiology, vol.29, issue.5, pp.878-84, 2002.
DOI : 10.1093/ije/29.5.878

J. Estève, E. Benhamou, and R. L. , Statistical methods in cancer research IV: descriptive epidemiology. Lyon: IARC Scientific Publication 128, International Agency for Research on Cancer, pp.37-44, 1994.

M. Coleman, J. Estève, P. Damiecki, A. Arslan, and H. Renard, Trends in cancer incidence and mortality, IARC Scientific Publications International Agency for Research on Cancer, vol.121, pp.27-38, 1993.

L. Remontet, J. Estève, A. Bouvier, P. Grosclaude, G. Launoy et al., Cancer incidence and mortality in France over the period, 1978.
URL : https://hal.archives-ouvertes.fr/hal-00427472

Z. Uhry, A. Belot, M. Colonna, N. Bossard, A. Rogel et al., National cancer incidence is estimated using the incidence/mortality ratio in countries with local incidence data: Is this estimation correct?, Cancer Epidemiology, vol.37, issue.3, pp.270-277, 2013.
DOI : 10.1016/j.canep.2012.12.007

F. Binder-foucard, A. Belot, P. Delafosse, L. Remontet, A. Woronoff et al., Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012. Partie 1 -Tumeurs solides. Saint-Maurice (Fra): Institut de veille sanitaire, p.122, 2013.

M. Colonna, N. Bossard, A. Guizard, L. Remontet, P. Grosclaude et al., Descriptive epidemiology of thyroid cancer in France: Incidence, mortality and survival, Annales d'Endocrinologie, vol.71, issue.2, pp.95-101, 2010.
DOI : 10.1016/j.ando.2009.11.006

URL : https://hal.archives-ouvertes.fr/inserm-00454647

D. Angelis, R. Grande, E. Inghelmann, R. Francisci, S. Micheli et al., Cancer prevalence estimates in Italy from, Tumori, vol.93, pp.392-399, 1970.

G. Engholm, J. Ferlay, N. Christensen, F. Bray, M. Gjerstorff et al., NORDCAN ? Cancer Incidence, Mortality, Prevalence and Prediction in the Nordic Countries, Version 4. Association of the Nordic Cancer Registries. Danish Cancer Society, 2011.

S. Altekruse, C. Kosary, M. Krapcho, N. Neyman, R. Aminou et al., MD: National Cancer Institute, editors. SEER Cancer Statistics Review Bethesda, 1975.

S. Chuang, G. Scelo, J. Tonita, S. Tamaro, J. Jonasson et al., Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries, International Journal of Cancer, vol.142, issue.10, pp.2390-2396, 2008.
DOI : 10.1002/ijc.23798

S. Chuang, M. Hashibe, G. Scelo, D. Brewster, E. Pukkala et al., Risk of Second Primary Cancer among Esophageal Cancer Patients: a Pooled Analysis of 13 Cancer Registries, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.6, pp.1543-1552, 2008.
DOI : 10.1158/1055-9965.EPI-07-2876

J. Jégu, A. Belot, C. Borel, L. Daubisse-marliac, B. Trétarre et al., Survival of patients with second cancer of the head and neck with respect to their previous history of cancer, 2015.

A. Bouvier, M. David, V. Jooste, M. Chauvenet, C. Lepage et al., Rising Incidence of Pancreatic Cancer in France, Pancreas, vol.39, issue.8, pp.1243-1249, 2010.
DOI : 10.1097/MPA.0b013e3181e1d5b3

B. Trétarre, L. Remontet, F. Ménégoz, J. Macé-lesec-'h, P. Grosclaude et al., Les cancers de l???ovaire : incidence et mortalit?? en France, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.34, issue.2, pp.154-61, 2005.
DOI : 10.1016/S0368-2315(05)82707-3

R. Capocaccia, M. Colonna, I. Corazziari, D. Angelis, R. Francisci et al., Measuring cancer prevalence in Europe: the EUROPREVAL Project, Annals of Oncology, vol.13, issue.6, pp.831-840, 2002.
DOI : 10.1093/annonc/mdf152